SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-096764
Filing Date
2011-11-09
Accepted
2011-11-09 07:00:17
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b87814e10vq.htm 10-Q 369602
2 EX-31.1 b87814exv31w1.htm EX-31.1 5930
3 EX-31.2 b87814exv31w2.htm EX-31.2 5949
4 EX-32.1 b87814exv32w1.htm EX-32.1 2841
5 EX-32.2 b87814exv32w2.htm EX-32.2 2862
  Complete submission text file 0000950123-11-096764.txt   1525249

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT idra-20110930.xml EX-101.INS 154203
7 EX-101 SCHEMA DOCUMENT idra-20110930.xsd EX-101.SCH 12064
8 EX-101 CALCULATION LINKBASE DOCUMENT idra-20110930_cal.xml EX-101.CAL 27591
9 EX-101 LABELS LINKBASE DOCUMENT idra-20110930_lab.xml EX-101.LAB 104477
10 EX-101 PRESENTATION LINKBASE DOCUMENT idra-20110930_pre.xml EX-101.PRE 68126
11 EX-101 DEFINITION LINKBASE DOCUMENT idra-20110930_def.xml EX-101.DEF 10240
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 111189556
SIC: 2836 Biological Products, (No Diagnostic Substances)